Adial Pharmaceuticals Competitors and Similar CompaniesClear all

Adial Pharmaceuticals's competitors and similar companies include Vertex Pharmaceuticals, BioMarin Pharmaceutical, CSL Behring and Zentiva.

	Adial Pharmaceuticals Adial Pharmaceuticals develops prescription medications for addiction and related disorders in the United States.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.	CSL Behring CSL Behring is a provider of life-saving medicines.	Zentiva Zentiva is a company that develops and manufactures generic medicines.
Founding Date	Founding Date 2010	Founding Date 1989	Founding Date 1997	Founding Date 1904	Founding Date 2003
Type	Type Public	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Charlottesville, US HQ Charlottesville, US	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations CZ HQ Tallinn, EE Paris, FR Mumbai, IN Milano, IT Milano, IT Rīga, LV see more
Employees	Employees 3	Employees 5,40013% increase	Employees 3,0015% increase	Employees 7,5692% decrease	Employees 3,4721% increase
Valuation ($)	Valuation ($) 6.7 m	Valuation ($) 121.4 b	Valuation ($) 13.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $3.2b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) Kč2.3b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods $717.4m (FY, 2025)	Cost of goods N/A	Cost of goods Kč807.2m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $2.5b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit Kč1.5b (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income $348.9m (FY, 2025)	Net income N/A	Net income (Kč831.2m) (FY, 2021)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries N/A	Countries 100 (Dec, 2020)	Countries 35 (Apr, 2023)
Patent Applications	Patent Applications N/A	Patent Applications N/A	Patent Applications 426 (FY, 2016)	Patent Applications 3 (Dec, 2020)	Patent Applications N/A
Trademark Applications	Trademark Applications N/A	Trademark Applications N/A	Trademark Applications N/A	Trademark Applications 1 (Dec, 2020)	Trademark Applications 4 (Apr, 2023)
Trademarks	Trademarks N/A	Trademarks N/A	Trademarks N/A	Trademarks 4 (Dec, 2020)	Trademarks 252 (Apr, 2023)